Ramm Pharma (TSE:RAMM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ramm Pharma Corp. has announced that the Ontario Superior Court of Justice has dismissed both the CAD 3,139,931.30 claim against them and their CAD 14,220,000 counterclaim in a legal dispute with Sergio Martines and Naturale Science Inc. The court did award a minor sum for unpaid expenses to Martines. Ramm continues its operations in cannabinoid pharmacology with a diversified portfolio in various international markets.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.